Related Experiment Videos
[Fabry disease, an ophthalmo-neuro-dermato-cardio-nephrologic problem]
Klinische Monatsblatter Fur Augenheilkunde
|May 1, 1995
Summary
This case study details a 47-year-old diagnosed with Fabry disease (FD), highlighting ocular and systemic manifestations. It emphasizes diagnostic and therapeutic strategies, underscoring the importance of interdisciplinary care for this rare genetic disorder.
Area of Science:
- Biochemistry
- Genetics
- Ophthalmology
Background:
- Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by alpha-galactosidase A deficiency.
- Accumulation of globotriaosylceramide leads to progressive multi-systemic pathology.
- Early diagnosis and management are crucial for improving patient outcomes.
Observation:
- A 47-year-old patient with histologically and biochemically confirmed Fabry disease is presented.
- The case highlights significant ocular findings, including characteristic corneal opacities (verticillata).
- Systemic manifestations affecting the kidneys, heart, and nervous system were also observed.
Findings:
- Biochemical assays confirmed deficient alpha-galactosidase A activity.
- Histopathological examination revealed characteristic sphingolipid accumulation in affected tissues.
- Multisystemic involvement necessitates a comprehensive diagnostic approach.
Implications:
- This case underscores the importance of recognizing diverse clinical presentations of Fabry disease.
- Prompt diagnosis and initiation of enzyme replacement therapy (ERT) or substrate reduction therapy (SRT) can mitigate disease progression.
- Effective management requires a collaborative, interdisciplinary approach involving various medical specialties.